切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (05) : 265 -267. doi: 10.3877/cma.j.issn.2095-3216.2015.05.010

所属专题: 文献

综述

炎症与血管钙化关系的研究进展
魏晓1, 欧三桃1,()   
  1. 1. 646000 四川泸州,泸州医学院附属医院肾病内科
  • 出版日期:2015-10-28
  • 通信作者: 欧三桃

Progress of researches on relationship between inflammation and vascular calcification

Xiao Wei1, Santao Ou1,()   

  1. 1. Department of Nephrology, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan 646000, China
  • Published:2015-10-28
  • Corresponding author: Santao Ou
  • About author:
    Corresponding author: Ou Santao, Email:
引用本文:

魏晓, 欧三桃. 炎症与血管钙化关系的研究进展[J]. 中华肾病研究电子杂志, 2015, 04(05): 265-267.

Xiao Wei, Santao Ou. Progress of researches on relationship between inflammation and vascular calcification[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(05): 265-267.

血管钙化(VC)是动脉粥样硬化、高龄、糖尿病、慢性肾脏病(CKD)等共同的病理改变,与心血管疾病高发病率和高死亡率密切相关。目前认为血管钙化是一个多因素参与调节的复杂的生物学过程,炎症可能通过直接或间接的方式参与血管钙化的形成与进展。本文就炎症与血管钙化的关系作一综述。

Vascular calcification (VC) is a common pathological change for atherosclerosis, old age, diabetes mellitus, and chronic kidney diseases (CKD), etc, and is highly associated with increased morbidity and mortality of cardiovascular disease (CVD). Now VC has been confirmed as a complex biological process regulated by multiple factors; inflammation may be involved in the formation and progress of VC through a direct or indirect manner. The relationship between inflammation and VC is reviewed in this paper.

1
Agharazii M, St-Louis R, Gautier-Bastien A, et al. Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification [J]. Am J Hypertens, 2015, 28(6): 746-755.
2
Bessueille L, Magne D. Inflammation: a culprit for vascular calcification in atherosclerosis and diabetes [J]. Cell Mol Life Sci, 2015, [Epub ahead of print].
3
Farrokhi E, Samani KG, Chaleshtori MH. Oxidized low-density lipoprotein increases bone sialoprotein expression in vascular smooth muscle cells via runt-related transcription factor 2 [J]. Am J Med Sci, 2015, 349(3): 240-243.
4
Wu M, Rementer C, Giachelli CM. Vascular calcification: an update on mechanisms and challenges in treatment [J]. Calcif Tissue Int, 2013, 93(4): 365-373.
5
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification [J]. Postgrad Med, 2014, 126(2): 54-64.
6
张旭升,周小欧,黄战军,等.大鼠血管钙化模型炎症因子及其受体的表达[J].岭南心血管病杂志,2013, 19(3): 341-345.
7
Tintut Y, Patel J, Parhami F, et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway [J]. Circulation, 2000, 102(21): 2636-2642.
8
Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification [J]? Circ Res, 2005, 96(12): 1248-1256.
9
Aoshima Y, Mizobuchi M, Ogata H, et al. Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α [J]. Nephrol Dial Transplant, 2012, 27(5): 1800-1806.
10
Dellegrottaglie S, Sanz J, Rajagopalan S.Molecular determinants of vascular calcification: a bench to bedside view[J].Curr Mol Med, 2006, 6(5): 515-524.
11
Yamada S, Tokumoto M, Tatsumoto N, et al. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia[J]. Am J Physiol Renal Physiol, 2014, 306(12): F1418-1428.
12
Masuda M, Miyazaki-Anzai S, Levi M, et al. PERK-eIF2a-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification [J]. J Am Heart Assoc, 2013, 2(5): 238-252.
13
Marinelli A, Orlandi L, Stivali G. C-reactive protein levels are associated with arterial media calcification in nondiabetic patients with end-stage renal disease on long-term hemodialysis [J]. Clinical Nephrology, 2011, 76(6): 425-434.
14
Ishimura E, Okuno S, Kitatani K, et al. C-reactive protein is a significant predictor of vascular calcif ication of both aorta and hand arteries [J]. Semin Nephrol, 2004, 24(5): 408-412.
15
Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization [J]. Nat Immunol, 2008, 9(8): 847-856.
16
Wen C, Yang X, Yan Z, et al. Nalp3 inflammasome is activated and required for vascular smooth muscle cell calcification [J]. Int J Cardiol, 2013, 168(3): 2242-2247.
17
彭利静,李慧,李超民,等.大鼠动脉钙化诱导过程中炎症小体复合物分子的变化[J].生物技术通讯,2014, 25(3): 388-390.
18
Zhan JK, Tan P, Wang YJ, et al. Exenatide can inhibit calcification of human VSMCs through the NF-kappa B/RANKL signaling pathway [J]. Cardiovasc Diabetol, 2014, 13(1): 153.
19
Kang YH, Jin JS, Son SM. Long term effect of high glucose and phosphate levels on the OPG/RANK/RANKL/TRAIL system in the progression of vascular calcification in rat aortic smooth muscle cells [J]. Korean J Physiol Pharmacol, 2015, 19(2): 111-118.
20
Qin X, Corriere MA, Matrisian LM, et al. Matrix metalloproteinase inhibition aortic calcification [J]. Arterioscler Thromb Vasc Biol, 2006, 26(7): 1510-1516.
21
Couchourel D, Aubry I, Delalandre A, et al. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production [J]. Arthritis Rheum, 2009, 60(5): 1438-1450.
22
彭朝胜,曹悦鞍.胎球蛋白-A与动脉钙化[J].海军总医院学报,2010, 23(1): 29-32.
23
Callegari A, Coons ML, Ricks JL, et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-κB ligand and interleukin 6 [J]. Vasc Res, 2014, 51(2): 118-131.
24
Ikeda K, Souma Y, Akakabe Y, et al. Macrophages play a unique role in the plaque calcification by enhancing the osteogenic signals exerted by vascular smooth muscle cells [J]. Biochem Biophys Res Commun, 2012, 425(1): 39-44.
25
Lee CT, Tsai YC, Su CY, et al. Interleukin 10 and residual kidney function are associated with risk of vascular calcification in patients undergoing peritoneal dialysis [J]. Clinical Nephrology, 2011, 75(5): 397-402.
26
赵安菊,黄颂敏,欧三桃,等.Cbfα-1和MCP-1在DN大鼠肾内小动脉中表达意义及相关性研究[J].中国现代医学杂志,2011, 21(33): 4109-4113.
27
Fuchs S, Lavi I, Tzang O, et al. Intracoronary monocyte chemoattractant protein 1 and vascular endothelial growth factor levels are associated with necrotic core, calcium and fibrous tissue atherosclerotic plaque components: an intracoronary ultrasound radiofrequency study [J]. Cardiology, 2012, 123(2): 125-132.
28
Guerrero F, Montes de Oca A, Aguilera-Tejero E, et al. The effect of vitamin D derivatives on vascular calcification associated with inflammation [J]. Nephrol Dial Transplant, 2012, 27(6): 2206-2212.
[1] 韩圣瑾, 周正武, 翁云龙, 黄鑫. 碳酸氢钠林格液联合连续性肾脏替代疗法对创伤合并急性肾损伤患者炎症水平及肾功能的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 376-381.
[2] 魏徐, 张鸽, 伍金林. 新生儿脓毒症相关性凝血病的监测和治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 379-386.
[3] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[4] 贾成朋, 王代宏, 陈华, 孙备. 可切除性胰腺癌预后术前预测模型的建立及应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 566-570.
[5] 伍学成, 李远伟, 袁武雄, 王建松, 石泳中, 卢强, 李卓, 陈佳, 刘哲, 滕伊漓, 高智勇. 炎症介质谱联合降钙素原在尿源性脓毒血症中的诊断价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 476-480.
[6] 王可, 范彬, 李多富, 刘奎. 两种疝囊残端处理方法在经腹腹膜前腹股沟疝修补术中的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 692-696.
[7] 苗软昕, 乔晞. Toll样受体在脓毒症性急性肾损伤中的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 210-214.
[8] 金艳盛, 董改琴, 李晓忠. 巨噬细胞在慢性肾脏病患者血管钙化中的作用与机制研究进展[J]. 中华肾病研究电子杂志, 2023, 12(04): 234-237.
[9] 郝然, 魏姗珊, 吴倩如, 李学民, 翟长斌. 干燥综合征血清微量元素变化及其与疾病严重程度的相关性研究[J]. 中华眼科医学杂志(电子版), 2023, 13(04): 215-220.
[10] 邹勇, 顾应江, 丁昊, 杨呈浩, 陈岷辉, 蔡昱. 基于Nrf2/HO-1及NF-κB信号通路探讨葛根素对大鼠脑出血后早期炎症反应及氧化应激反应的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 271-277.
[11] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[12] 朱风尚, 舍玲, 丁永年, 杨长青. 警惕炎症性肠病与少见肠道疾病的鉴别诊断[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 273-276.
[13] 张赟辉, 罗军, 刘栗丽, 汪宏, 耿克明. 腹膜透析与血液透析对老年终末期肾病患者营养状况及炎症反应的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 419-423.
[14] 刘感哲, 艾芬. MiRNA-210通过抑制HIF-1α的表达改善大鼠血管性认知功能障碍[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 489-494.
[15] 刘天姿, 王宝军. Toll样受体4在阿尔茨海默病中的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 404-409.
阅读次数
全文


摘要